The Government and Companies Are Both Preparing for the (As Yet Unannounced) Pharma Tariffs
Shares:
One of the great freedoms of the newsletter format is that they can be as long or as short as they need to be. So while I’m going to be
My default assumption about most of the PBM reform proposals that have been circulating on Capitol Hill is that they’re smallball: they snack around the edge of the PBM business
This journal article makes the case -- via analysis of claims data -- that patients almost never fill scripts for obesity medicines. The topline is that 10 of every 11